Skip to content
Screener

Absci Corporation ABSI Total Current Liabilities

Total Current Liabilities at other companies

Schrodinger logo
SchrodingerSDGR
$173.85M+11.6%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$119.89M-26.9%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$85.16M+20.5%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$53.19M-20.6%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$41.7M-5.3%
Assembly Biosciences logo
Assembly BiosciencesASMB
$35M-24.9%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.41B+235%
Enterprise value$1.4B+279%
P/S765.8×+664×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Absci Corporation’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:24 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001672688-26-000088
(In thousands, except for share and per share data)March 31, 2026December 31, 2025
Long-term debt413873
Operating lease obligations1,8571,805
Deferred revenue450739
Total current liabilities20,03022,765
Operating lease obligations, net of current portion2,1452,624
Deferred revenue, long-term641436
Other long-term liabilities8061,023
TOTAL LIABILITIES23,62226,848

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Absci Corporation's total current liabilities?
Absci Corporation (ABSI) reported total current liabilities of $20.03M in Q1 2026.
How has Absci Corporation's total current liabilities changed year-over-year?
Absci Corporation's total current liabilities decreased by 26.6% year-over-year, from $27.28M to $20.03M.
What is the long-term trend for Absci Corporation's total current liabilities?
Over 5 years (2020 to 2025), Absci Corporation's total current liabilities has grown at a 17.7% compound annual growth rate (CAGR), from $10.1M to $22.77M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Absci Corporation's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude